The shift from hosting daily ‘Andrea Mitchell Reports’ to a wider presence in the NBC News Group will follow the U.S. Presidential inauguration in Jan. 2025. By Etan Vlessing Canada Bureau ...

Scott and Andrea Swift recognized their daughter’s talent early and supported her in all her pursuits. “She was always singing music when she was 3, 5, 6, 7, years old,” Scott told ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

Your favorite tenor’s favorite tenor may be coming to a venue near you. Andrea Bocelli just announced he’s returning to the road in February and June 2025 for ten concerts with local ...

As one of the leading Japanese pharmaceutical companies with headquarters in Europe, Daiichi Sankyo aims to revolutionize treatment standards. Daiichi Sankyo, a pharmaceutical group boasting over ...

New Delhi, The Delhi High Court on Tuesday ordered auctioning of the Fortis trademark in connection with the ₹3,500 crore arbitral award passed in favour of Japanese pharma major Daiichi Sankyo ...

Keoghan continued, “[Andrea Arnold] is almost trying to break you down in the gentlest way so you can be honest and truthful.” He added, “‘Bird’ has been the most artistic experience ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

The campaign is presented by Daiichi-Sankyo and AstraZeneca, while Merck serves as a gold-level sponsor and Eli Lilly, Pfizer and Guardant come aboard as community sponsors. In the campaign’s ...

Shares in Esperion Therapeutics lost more than half of their value after it disclosed a dispute with Daiichi Sankyo on a $300 million milestone payment relating to cholesterol drug Nexletol.

Just over a decade after being acquired by Daiichi Sankyo, US biotech Plexxikon will be shuttered at the end of March, with its R&D projects transferred to other areas of the Japanese group. It's ...